Mean and standard error was calculated for all quantitative experiments
Treatment may be relevant at a BMI of at least 30, or a BMI of 27 in combination with at least one weight-related complication such as high blood pressure, dyslipidemia (elevated blood lipids), or obstructive sleep apnea
Brad Rovin, MD , chief of nephrology at The Ohio State University Wexner Medical Center, says he orders uACR testing very frequently
Our findings show that SGLT2 inhibitors appear more effective in reducing cardiovascular events in older people, and this may be one piece of information that clinicians can take into account when deciding with individual patients what is best for them. Our findings also suggest that clinicians should not be put off by smaller changes in blood sugar in older people, as the cardiovascular benefits were greater despite a smaller improvement in blood sugar, he added.
Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair
Consistent documentation improves team accuracy during repeated preparations
